Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
05/2005
05/25/2005DE10352067A1 Isopentylcarboxanilide Isopentylcarboxanilide
05/25/2005DE10349497A1 N-substituierte Pyrazolylcarboxanilide N-substituted pyrazolylcarboxanilides
05/25/2005CN1620427A Pseudo-nervonic amide and cosmetics composition containing the same
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620421A Substituted alkyl diamine
05/25/2005CN1620403A Preparation of safety brominized reagent
05/25/2005CN1618787A Chemical synthesis process of 2-hydrixy-5-amudo benzophenone compounds
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/24/2005US6897323 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
05/24/2005US6897306 3-heterocyclylpropanohydroxamic acids
05/24/2005US6897263 Betaine esters
05/24/2005US6897220 Antiproliferative agents
05/24/2005CA2174000C Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
05/19/2005WO2005044791A2 2-halogen-6-alkyl-phenyl-substituted tetramic acid derivatives
05/19/2005WO2005044787A1 Phenetanolamine derivatives
05/19/2005WO2005044778A1 Use of alkene carboxlic acid n alkylamides as flavouring agents
05/19/2005WO2005044191A2 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2005028421A3 Process for the synthesis of 6-amino-4-[(3-chloro-4-fluorophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile
05/19/2005WO2005016868A3 Matrix metalloproteinase inhibitors
05/19/2005WO2005015158A9 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005US20050107623 Method of making hydroxyalkyl amide containing reduced level of unreacted alkanolamine
05/19/2005US20050107619 Z-substituted acrylamides, methods for production thereof and agents comprising the same
05/19/2005US20050107608 Ligands for use in catalytic processes
05/19/2005US20050107448 Calcium receptor antagonists
05/19/2005US20050107355 Agonists of the kappa opioid receptor for treating gastrointestinal disorders, pain, and pruritus; N-{2-[(S)-3-hydroxy-pyrrolidin-1-yl]-(S)-1-phenyl-ethyl}-N-methyl-2-phenylamino-acetamide
05/19/2005US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists
05/19/2005US20050107248 Metallic catalysts for chemo-, regio-and stereoselective reactions, and corresponding precursors
05/19/2005DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005CA2544548A1 2-halogen-6-alkyl-phenyl-substituted tetramic acid derivatives
05/18/2005CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/18/2005CN1202093C Substituted heterocyclic compound
05/18/2005CN1202087C Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
05/17/2005US6894197 Process for producing fluorinated alcohol
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/17/2005CA2487680A1 A lubricating oil composition for automatic transmissions
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042494A1 Isopentyl carboxanilides for combating undesired micro-organisms
05/12/2005WO2005042481A2 COMPOUNDS AND RELATED METHODS FOR MUTANT p53 REACTIVATION
05/12/2005WO2005042480A2 N-substituted pyrazolyl carboxanilides
05/12/2005WO2005042472A2 Hydroxypropyl amides for the treatment of alzheimer’s disease
05/12/2005WO2005042441A1 Method and apparatus for the use of [11c] carbon monixide in labeling synthesis by photo-initiated carbonylation
05/12/2005WO2005041684A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/12/2005WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2
05/12/2005US20050101781 Eponemycin and epoxomicin analogs and uses thereof
05/12/2005US20050101744 T-butyl cascade polymers
05/12/2005US20050101672 Dissolving in solvent in which nateglinide is highly soluble such as ethanol, dioxane, dichloromethane, or acetone; adding water or hexane in which nateglinide is not soluble; crystallization
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/12/2005US20050097813 Method of purifying hydroxyalkyl amide
05/12/2005CA2544335A1 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
05/12/2005CA2543756A1 Hydroxypropyl amides for the treatment of alzheimer's disease
05/12/2005CA2543054A1 Isopentylcarboxanilides for combating undesired micro-organisms
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1257526B1 Aniline-derived ligands for the thyroid receptor
05/11/2005EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
05/11/2005CN1615295A Compounds for treatment of inflammation, diabetes and related disorders
05/11/2005CN1615134A Pharmaceutical compositions comprising valsartan and NEP inhibitors
05/11/2005CN1613845A Preparation of amidated natural metha camphor as effective algefacient
05/11/2005CN1200945C Process for acylation of amino alcohols
05/11/2005CN1200703C Use of pentanoate derivant
05/11/2005CN1200699C Anthracyclinone derivatives and their use in amyloidosis
05/10/2005US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain
05/10/2005CA2296450C Polyalkanolamide tackifying resins for creping adhesives
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040100A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005WO2005040093A1 Amino alcohol derivative, medicinal composition containing the same, and use of these
05/06/2005WO2005040091A1 Aminoalkanol derivatives
05/06/2005WO2005039494A2 Inhibitors of rnase p proteins as antibacterial compounds
05/06/2005WO2004113271A8 A method for the preparation of crystalline dexloxiglumide
05/06/2005CA2542494A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005CA2542064A1 Tao kinase modulators and methods of use
05/06/2005CA2541894A1 Amino alcohol derivative, medicinal composition containing the same, and use of these
05/06/2005CA2539277A1 Aminoalkanol derivatives
05/05/2005US20050096485 Thyronamine derivatives and analogs and methods of use thereof
05/05/2005US20050095280 Cationic lipids as delivery vectors for nucleic acids, peptides and other synthetic drugs, in vitro and in vivo; form stable lamellar structures (liposomes) at physiological pH but destabilize to micelles at acidic and alkaline pH
05/04/2005EP1337506A4 Improved process for production of gabapentin intermediate
05/04/2005EP1259477B1 Aminoadamantane derivatives as therapeutic agents
05/04/2005CN1612887A Phosphino-aminophosphines
05/04/2005CN1612871A Processes and intermediates for preparing benzyl epoxides
05/04/2005CN1612857A Geranyl compounds
05/03/2005US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/03/2005US6888015 Sphingolipid synthesis inhibitor
05/03/2005US6888012 Reducing an alpha -haloketone compound by asymmetric hydrogen transfer in presence of a group 9 transition metal compound having a substituted or unsubstituted cyclopentadienyl group and an optically active diamine compound
05/03/2005US6887995 Reacting N-aryl-O-alkylcarbamate with an amide derivative in the presence of a lithium cation, a base, and a nucleophile
05/03/2005US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/03/2005US6887877 Viricide for hepatitis virus
05/03/2005CA2149886C Process for preparing tetrazolyl-benzopyranones
05/03/2005CA2133337C Compounds useful for treating allergic or inflammatory diseases
05/03/2005CA2114114C Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
04/2005
04/28/2005WO2005037793A1 Cyclopentene compounds
04/28/2005WO2005037770A1 Amides, polyolefin resin compositions, and moldings
04/28/2005WO2005037210A2 Photocleavable isotope-coded affinity tags
04/28/2005WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation
04/28/2005WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals
04/28/2005US20050090690 via condensation reaction between a diacid, a monoacid, and a diisocyanate; use in phase change ink after mixing with a colorant; for example reactants are, 1,6-diisocyanatohexane, a C47+ fatty acid, and a branched long chain diacid
04/28/2005US20050090687 Oxidizing primary amino alcohol in presences of dichromate and/or chromium oxide catalyst to form acid/ketone
04/28/2005US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 289